347 related articles for article (PubMed ID: 17105576)
1. Canine leishmaniasis chemotherapy: dog's clinical condition and risk of Leishmania transmission.
João A; Pereira MA; Cortes S; Santos-Gomes GM
J Vet Med A Physiol Pathol Clin Med; 2006 Dec; 53(10):540-5. PubMed ID: 17105576
[TBL] [Abstract][Full Text] [Related]
2. Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol.
Manna L; Reale S; Vitale F; Picillo E; Pavone LM; Gravino AE
Vet J; 2008 Aug; 177(2):279-82. PubMed ID: 17553711
[TBL] [Abstract][Full Text] [Related]
3. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
Oliva G; Foglia Manzillo V; Pagano A
Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
[TBL] [Abstract][Full Text] [Related]
4. Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol.
Torres M; Bardagí M; Roura X; Zanna G; Ravera I; Ferrer L
Vet J; 2011 Jun; 188(3):346-51. PubMed ID: 20594876
[TBL] [Abstract][Full Text] [Related]
5. Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate.
Ikeda-Garcia FA; Lopes RS; Marques FJ; de Lima VM; Morinishi CK; Bonello FL; Zanette MF; Perri SH; Feitosa MM
Vet Parasitol; 2007 Feb; 143(3-4):254-9. PubMed ID: 16996214
[TBL] [Abstract][Full Text] [Related]
6. Clinical follow-up examination after treatment of canine leishmaniasis.
Moritz A; Steuber S; Greiner M
Tokai J Exp Clin Med; 1998 Dec; 23(6):279-83. PubMed ID: 10622623
[TBL] [Abstract][Full Text] [Related]
7. Monitoring the reverse to normal of clinico-pathological findings and the disease free interval time using four different treatment protocols for canine leishmaniosis in an endemic area.
Paradies P; Sasanelli M; Amato ME; Greco B; De Palo P; Lubas G
Res Vet Sci; 2012 Oct; 93(2):843-7. PubMed ID: 22296941
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
[TBL] [Abstract][Full Text] [Related]
9. Characterization of circulating lymphocyte subpopulations in canine leishmaniasis throughout treatment with antimonials and allopurinol.
Miranda S; Martorell S; Costa M; Ferrer L; Ramis A
Vet Parasitol; 2007 Mar; 144(3-4):251-60. PubMed ID: 17110042
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study.
Esfandiarpour I; Dabiri SH
Int J Dermatol; 2007 Aug; 46(8):848-52. PubMed ID: 17651170
[TBL] [Abstract][Full Text] [Related]
11. PCR follow-up examination after treatment of canine leishmaniosis (CaL).
Steuber S; Moritz A; Schirrmann I; Greiner M
Tokai J Exp Clin Med; 1998 Dec; 23(6):285-92. PubMed ID: 10622624
[TBL] [Abstract][Full Text] [Related]
12. Some remarks about the LeishVet directions for the treatment of canine leishmaniasis.
Lamothe J
Vet Parasitol; 2010 May; 169(3-4):416-7; author reply 418-20. PubMed ID: 20106598
[No Abstract] [Full Text] [Related]
13. Variation of proteinuria in dogs with leishmaniasis treated with meglumine antimoniate and allopurinol: a retrospective study.
Pierantozzi M; Roura X; Paltrinieri S; Poggi M; Zatelli A
J Am Anim Hosp Assoc; 2013; 49(4):231-6. PubMed ID: 23690493
[TBL] [Abstract][Full Text] [Related]
14. The effects of prednisone on haemostasis in leishmaniotic dogs treated with meglumine antimoniate and allopurinol.
Cortese L; Pelagalli A; Piantedosi D; Mastellone V; Di Loria A; Lombardi P; Ciaramella P; Avallone L
Vet J; 2008 Sep; 177(3):405-10. PubMed ID: 17629526
[TBL] [Abstract][Full Text] [Related]
15. Use of meglumine antimoniate in canine leishmaniasis.
Lamothe J
Vet Rec; 2004 Mar; 154(12):378. PubMed ID: 15074332
[No Abstract] [Full Text] [Related]
16. Management of leishmanial osteolytic lesions in a hypothyroid dog by partial tarsal arthrodesis.
Franch J; Pastor J; Torrent E; Lafuente P; Diaz-Bertrana MC; Munilla A; Durall I
Vet Rec; 2004 Oct; 155(18):559-62. PubMed ID: 15559422
[TBL] [Abstract][Full Text] [Related]
17. Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis.
Miró G; Oliva G; Cruz I; Cañavate C; Mortarino M; Vischer C; Bianciardi P
Vet Dermatol; 2009 Oct; 20(5-6):397-404. PubMed ID: 20178476
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis.
Oliva G; Gradoni L; Cortese L; Orsini S; Ciaramella P; Scalone A; de Luna R; Persechino A
Ann Trop Med Parasitol; 1998 Mar; 92(2):165-71. PubMed ID: 9625912
[TBL] [Abstract][Full Text] [Related]
19. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
[TBL] [Abstract][Full Text] [Related]
20. Hepatic fibropoiesis in dogs naturally infected with Leishmania (Leishmania) infantum treated with liposome-encapsulated meglumine antimoniate and allopurinol.
Castro RS; de Amorim IFG; Pereira RA; Silva SM; Pinheiro LJ; Pinto AJW; Azevedo EG; Demicheli C; Caliari MMV; Mosser DM; Michalick MSM; Frezard FJG; Tafuri WL
Vet Parasitol; 2018 Jan; 250():22-29. PubMed ID: 29329619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
